EQUITY RESEARCH MEMO

Precision Spine

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

Precision Spine is a privately held US medical device company specializing in spinal pathology solutions. Through its subsidiaries, Spinal USA and Precision Medical, it offers a comprehensive line of spinal implants and instruments manufactured in the USA. The company differentiates itself by providing high-quality, competitively priced products backed by strong customer service. With over two decades of experience since its founding in 2003, Precision Spine has established a presence in the spinal surgery market, though its private status limits public financial disclosure. The company's focus on domestic manufacturing and customer support positions it well in an industry where quality and reliability are paramount.

Upcoming Catalysts (preview)

  • Q3 2026FDA 510(k) Clearance for Next-Generation Interbody Fusion Device70% success
  • Q4 2026Strategic Partnership or Distribution Agreement for Minimally Invasive Surgery (MIS) Product Line60% success
  • Q1 2027Expansion into International Markets via CE Mark Certification for Key Products55% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)